“鸡尾酒”式免疫干预法防治1型糖尿病的最新研究进展
摘要
1型糖尿病(T1DM)是一种自身免疫性疾病,以遗传为基础.在某些环境因素作用下.诱发机体免疫系统功能障碍导致胰岛β细胞自身免疫性损伤,使其丧失合成和分泌胰岛素能力,引起糖代谢调节絮乱的自身免疫性疾病;
出处
《内科理论与实践》
2013年第3期221-224,共4页
Journal of Internal Medicine Concepts & Practice
参考文献24
-
1Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes [J]. Nature, 2010, 464(7293): 1293-1300.
-
2Maahs DM, Rewers M. Editorial: mortality and renal disease in type 1 diabetes mellitus--progress made, more to be done [J]. J Clin Endocrinol Metab, 2006,91 (10): 3757-3759.
-
3The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual βcellfunction in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial [J]. Ann Intern Med, 1998, 128(7): 517-523.
-
4Bresson D, yon Herrath M. Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside [J]. Diabetes Care, 2009, 32(10): 1753-1768.
-
5Michels AW, Eisenbarth GS. Immune intervention in type 1 diabetes [J]. Semin Immunol, 2011, 23(3): 214- 219.
-
6Penaranda C, Tang Q, Bluestone JA. Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells [J]. J Immunol, 2011, 187(4): 2015-2022.
-
7Bach JF. Anti-CD3 antibodies for type 1 diabetes: beyond expectations [J]. Lancet, 2011, 378(9790): 459- 460.
-
8Sprangers B, Van der Schueren B, GiUard P, et al. Otelixizumab in the treatment of type 1 diabetes mellitus [J]. Immunotherapy, 2011, 3(11): 1303-1316.
-
9Herold KC, Gitelman S, Greenbaum C, et al. Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years [J]. Clin Immunol, 2009, 132(2): 166-173.
-
10Bresson D, Togher L, Rodrigo E, et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs [J]. J Clin Invest, 2006, 116(5): 1371-1381.
二级参考文献20
-
1Bottini N.Role of PTPN22 in type 1 diabetes and other autoimmune diseases,Seminars in Immunology.2006,18:207-213.
-
2Knip M,Veijola R,Virtanen SM,et al.Environmental triggers and determinants of type Ⅰ diabetes.Diabetes,2005,54 (Suppl 2):S125-S136.
-
3Burt RK,Arnold R,Emmons R,et al.Stem cell therapy for autoimmune disease:overview of concepts from the snowbird 2002 tolerance and tissue regeneration meeting.Bone Marrow Transplantat,2003,32:3-5.
-
4Beard ME,Willis JA,Scott RS,et al.Is type 1 diabetes transmissible by bone marrow allograft? Diabetes Care.2002,25:799-800.
-
5Voltarelli JC,Couri CE,Stracieri AB,et al.Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.JAMA,2007,297:1568-1576.
-
6Skyler JS.Cellular therapy for type 1 diabetes:has the time come?JAMA,2007,297:1599-1600.
-
7Tyndall A,Fassas A,Passweg J,et al.Autologous haematopoietic stem cell transplants for autoimmune disease-feasibility and transplantrelated mortality.Autoimmune disease and lymphoma working parties of theEuropean group for blood and marrow transplantation,the european league against rheumatism and the international stem cell project for autoimmune disease.Bone Marrow Transplant,1999,24:729-734.
-
8Openshaw H,Nash RA,McSweeney PA.High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease:clinical review.Biol Blood Marrow Transplant,2002,8:233 -248.
-
9Tyndall A,Passweg J,Gratwohl A.Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000.Ann Rheum Dis,2001,60:702-707.
-
10Couri CEB,Oliveira MCB,Stracieri ABPL,et al.C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.JAMA,2009,301:1573-1579.
共引文献13
-
1李光伟.是你想做什么,还是这世界想听什么?——浅谈临床科研定位与论文发布[J].中华内分泌代谢杂志,2010,26(12):1017-1018.
-
2顾卫琼.造血干细胞移植治疗1型糖尿病[J].内科理论与实践,2011,6(4):275-278. 被引量:4
-
3谷奕,巩纯秀.糖尿病专业教育和儿童糖尿病的治疗[J].临床儿科杂志,2011,29(12):1101-1104. 被引量:7
-
4姚金萍,段炼,童强,徐梓辉.自体骨髓干细胞移植治疗2型糖尿病的安全性及有效性[J].第三军医大学学报,2012,34(1):74-77. 被引量:5
-
5冯凯,许怡薇,叶扶光,肖漓,马锡慧,高钰,张鑫,姚尚志,石炳毅.自体骨髓移植治疗儿童1型糖尿病[J].军医进修学院学报,2012,33(1):16-18. 被引量:1
-
6叶蕾,顾卫琼,王卫庆.1型糖尿病和自身免疫性甲状腺疾病的遗传易患性研究进展[J].中华糖尿病杂志,2012,4(3):179-181. 被引量:3
-
7顾卫琼,宁光.自体造血干细胞移植治疗1型糖尿病的前景与出路[J].中华内分泌代谢杂志,2012,28(6):445-447. 被引量:1
-
8李莉蓉,朱大龙.自体外周造血干细胞移植——治疗1型糖尿病的新曙光[J].中华内分泌代谢杂志,2012,28(6):448-451. 被引量:21
-
9邓超,向宇飞,周智广.1型糖尿病免疫治疗研究进展[J].中华内分泌代谢杂志,2013,29(3):263-266. 被引量:4
-
10侯韬,石远凯.自体造血干细胞移植对1型糖尿病患者血糖控制作用的对照研究[J].中国现代医生,2014,52(26):34-37. 被引量:1
-
1“鸡尾酒”疗法治疗艾滋病效果依然显著[J].传染病网络动态,2003(9):15-15.
-
2范中有,赵峥,王龙霄,郭会军,柳凯,邓国梅.鸡尾酒配合中医辨证治疗HIV/AIDS临床疗效观察[J].河南预防医学杂志,2010,21(3):211-214. 被引量:3
-
3盛树力,张万江,陈源源,鲁梅花,赵咏梅.调节糖代谢的多肽及其生理作用[J].基础医学与临床,1993,13(3):21-24.
-
4王同成,唐元升,王际军.中药鸡尾酒疗法治疗不稳定型心绞痛疗效观察[J].山东医药,2006,46(31):65-66. 被引量:1
-
5马晓媛,肖雅田,李星,梁华平.创伤后多器官功能障碍综合征预警指标的研究进展[J].中华创伤杂志,2016,32(1):89-92. 被引量:3
-
6田宇红,丛梅,何继东.自身免疫性胰腺炎患者的护理[J].中华现代护理杂志,2014,20(25):3246-3248. 被引量:6
-
7抗生素辅“鸡尾酒”有助延长艾滋病患者生命[J].药物与人,2010(5):5-5.
-
8王阳,曾其毅.脓毒症与线粒体功能障碍研究进展[J].中国循证儿科杂志,2008,3(4):305-312.
-
9英国医生提出用“鸡尾酒"法治艾滋病[J].今日应用医学,1997,2(1):53-53.
-
10林旭东,徐莲芝,冯毅,李洁,裴丽健,沈彤庆,邵一鸣.病毒载量和T淋巴细胞计数在HIV感染者临床治疗疗效观察中的应用[J].中华实验和临床病毒学杂志,2002,16(3):211-214. 被引量:3